Amarin Corp. Plc (AMRN)
16.60
+1.34
(+8.82%)
USD |
NASDAQ |
Jan 22, 16:00
16.60
0.00 (0.00%)
After-Hours: 20:00
Amarin Research and Development Expense (TTM): 17.36M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Trinity Biotech Plc | 4.019M |
| Jazz Pharmaceuticals Plc | 809.33M |
| DBV Technologies SA | 95.77M |
| Cellectis SA | 70.72M |
| Biodexa Pharmaceuticals Plc | 6.352M |